Marshall Wace North America’s Halozyme HALO Stock Holding History

Marshall Wace North America’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41,007	Closed	-$1.71M	–	1580
2021 Q1	$1.71M	Buy	+41,007	New	+$1.87M	0.01%	877
2020 Q1	–	Sell	-32,451	Closed	-$575K	–	1383
2019 Q4	$575K	Buy	+32,451	New	+$562K	﹤0.01%	804
2019 Q3	–	Sell	-99,599	Closed	-$1.71M	–	1395
2019 Q2	$1.71M	Buy	99,599 +34,167	+52%	+$551K	0.01%	609
2019 Q1	$1.05M	Buy	+65,432	New	+$1.06M	0.01%	652
2017 Q3	–	Sell	-71,929	Closed	-$935K	–	1364
2017 Q2	$935K	Buy	71,929 +4,220	+6%	+$56.4K	0.01%	952
2017 Q1	$880K	Buy	+67,709	New	+$856K	0.01%	723

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace North America's HALO Position: Q2 2021 in Review

Marshall Wace North America sold out of Halozyme (HALO) in Q2 2021, closing a stake of 41,007 shares — an estimated $1.71M sold.

Marshall Wace North America first reported a position in HALO in Q1 2017 and held it in 6 quarters. The position peaked at $1.71M in Q2 2019. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

Marshall Wace North America reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 41,007 Halozyme shares in Q2 2021, an estimated $1.71M.
Marshall Wace North America first reported a position in Halozyme in Q1 2017 and held it in 6 quarters.
Marshall Wace North America's Halozyme position peaked at $1.71M in Q2 2019.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.